We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Dr. Andrew Pearlman has > 35 years’ experience founding and managing US/Israel biotechnology and medical device companies. A biophysicist, Dr. Pearlman has invented, licensed, developed and managed medical devices and biotechnologies from business and product concept through technology development, IP, clinical trials, regulatory approval, manufacturing, and product sales. Dr. Pearlman has raised > $120mm for new biomedical ventures he founded in Israel, including Medgenics, a gene therapy company he took from laboratory research stage through Phase 2 clinical trials and through IPOs on both the London Stock Exchange and the NYSE, building it to over $350 million in market cap. In the past year, Dr. Pearlman has founded Galimedix, built a world class team, completed seed financing and in-licensed the key technology. Dr. Pearlman holds a Ph.D. in Biophysics from UC Berkeley, with doctoral thesis under Nobel Laureates Professors Melvin Calvin and Donald Glaser.
This speaker's sessions: